Regulus Therapeutics Inc (RGLS)

NASDAQ
Currency in USD
8.1600
+0.0200(+0.25%)
Closed·
Showing Regulus Therapeutics historical data. For real-time data please try another search
Fair Value
Day's Range
8.07008.1800
52 wk Range
0.83018.3450
Key Statistics
Edit
Prev. Close
8.16
Open
8.15
Day's Range
8.07-8.18
52 wk Range
0.8301-8.345
Volume
9.34M
Average Volume (3m)
2.7M
1-Year Change
368.97%
Book Value / Share
1.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RGLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Regulus Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Regulus Therapeutics Inc Company Profile

Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.

Compare RGLS to Peers and Sector

Metrics to compare
RGLS
Peers
Sector
Relationship
P/E Ratio
−13.0x0.0x−0.5x
PEG Ratio
−0.260.000.00
Price/Book
8.9x0.0x2.6x
Price / LTM Sales
-0.0x3.2x
Upside (Analyst Target)
10.3%0.0%45.3%
Fair Value Upside
Unlock0.0%7.4%Unlock

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.15 / -0.25
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RGLS Income Statement

People Also Watch

4.380
CURI
-0.45%
13.85
DOMO
+3.05%
6.220
AGEN
-8.93%
5.390
SLDB
-1.46%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.